11.07.2015 Views

Novel genetic and epigenetic alterations in ... - Ous-research.no

Novel genetic and epigenetic alterations in ... - Ous-research.no

Novel genetic and epigenetic alterations in ... - Ous-research.no

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

12. Duval A, Reperant M, Hamel<strong>in</strong> R (2002) Comparative analysis of mutationfrequency of cod<strong>in</strong>g <strong>and</strong> <strong>no</strong>n cod<strong>in</strong>g short mo<strong>no</strong>nucleotide repeats <strong>in</strong> mismatchrepair deficient colorectal cancers. Oncogene 21(52): 8062-806613. Hanahan D, We<strong>in</strong>berg RA (2000) The hallmarks of cancer. Cell 100(1): 57-7014. Woerner SM, Benner A, Sutter C, Schiller M, Yuan YP, Keller G, Bork P, DoeberitzMK, Gebert JF (2003) Pathogenesis of DNA repair-deficient cancers: a statisticalmeta-analysis of putative Real Common Target genes. Oncogene 22(15): 2226-223515. Duffy MJ, van DA, Haglund C, Hansson L, Hol<strong>in</strong>ski-Feder E, Klapdor R, Lamerz R,Peltomaki P, Sturgeon C, Topolcan O (2007) Tumour markers <strong>in</strong> colorectal cancer:European Group on Tumour Markers (EGTM) guidel<strong>in</strong>es for cl<strong>in</strong>ical use. Eur JCancer 43(9): 1348-136016. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, SomerfieldMR, Hayes DF, Bast RC, Jr. (2006) ASCO 2006 update of recommendations for theuse of tumor markers <strong>in</strong> gastro<strong>in</strong>test<strong>in</strong>al cancer. J Cl<strong>in</strong> Oncol 24(33): 5313-532717. Fern<strong>and</strong>ez-Peralta AM, Nejda N, Oliart S, Med<strong>in</strong>a V, Azcoita MM, Gonzalez-AguileraJJ (2005) Significance of mutations <strong>in</strong> TGFBR2 <strong>and</strong> BAX <strong>in</strong> neoplasticprogression <strong>and</strong> patient outcome <strong>in</strong> sporadic colorectal tumors with highfrequencymicrosatellite <strong>in</strong>stability. Cancer Genet Cytogenet 157(1): 18-2418. Io<strong>no</strong>v Y, Yamamoto H, Krajewski S, Reed JC, Perucho M (2000) Mutational<strong>in</strong>activation of the proapoptotic gene BAX confers selective advantage dur<strong>in</strong>gtumor clonal evolution. Proc Natl Acad Sci U S A 97(20): 10872-1087719. Jung B, Smith EJ, Doctolero RT, Gervaz P, Alonso JC, Miyai K, Keku T, S<strong>and</strong>ler RS,Carethers JM (2006) Influence of target gene mutations on survival, stage <strong>and</strong>histology <strong>in</strong> sporadic microsatellite unstable colon cancers. Int J Cancer 118(10):2509-251320. Watanabe T, Wu TT, Catala<strong>no</strong> PJ, Ueki T, Satria<strong>no</strong> R, Haller DG, Benson AB, III,Hamilton SR (2001) Molecular predictors of survival after adjuvant chemotherapyfor colon cancer. N Engl J Med 344(16): 1196-120621. Samowitz WS, Curt<strong>in</strong> K, Neuhausen S, Schaffer D, Slattery ML (2002) Prog<strong>no</strong>sticimplications of BAX <strong>and</strong> TGFBRII mutations <strong>in</strong> colon cancers withmicrosatellite <strong>in</strong>stability. Genes Chromosomes Cancer 35(4): 368-37122. Lewis KA, Bakkum-Gamez J, Loewen R, French AJ, Thibodeau SN, Cliby WA (2007)Mutations <strong>in</strong> the ataxia telangiectasia <strong>and</strong> rad3-related-checkpo<strong>in</strong>t k<strong>in</strong>ase 1DNA damage response axis <strong>in</strong> colon cancers. Genes Chromosomes Cancer 46(12):1061-106823. Nehls O, Okech T, Hsieh CJ, Enz<strong>in</strong>ger T, Sarbia M, Borchard F, Gruenagel HH, GacoV, Hass HG, Arkenau HT, Hartmann JT, Porschen R, Gregor M, Klump B (2007)25

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!